{
    "id": "dashboard-item-1759906076097-medication-timeline",
    "type": "component",
    "x": 1750,
    "y": 100,
    "width": 1600,
    "height": "auto",
    "componentType": "MedicationTimeline",
    "color": "#ffffff",
    "description": "",
    "content": {
        "title": "Medication Timeline",
        "component": "MedicationTimeline",
        "patientData": {
            "patient": {
                "name": "Sarah Miller",
                "date_of_birth": "1981-06-03",
                "age": 43,
                "sex": "Female",
                "age_at_first_encounter": 43,
                "identifiers": {
                "mrn": "SM43850603"
                }
            },
            "riskLevel": "high",
            "primaryDiagnosis": "Severe Drug-Induced Liver Injury (Methotrexate-related)",
            "problem_list": [
                {"name": "Type 2 Diabetes Mellitus", "status": "active"},
                {"name": "Essential Hypertension", "status": "active"},
                {"name": "Rheumatoid Arthritis", "status": "active"},
                {"name": "Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD/MASH)", "status": "active"},
                {"name": "Severe Methotrexate-induced Drug-Induced Liver Injury (DILI)", "status": "active"},
                {"name": "Acute jaundice episode (2024-08)", "status": "resolved/improving"}
            ]
        },
        "props": {
            "encounters": [
    {
      "encounter_no": 1,
      "date": "2015-08-10",
      "type": "Rheumatology Initial Consult",
      "provider": "Dr. Elizabeth Hayes",
      "medications": [
        "Methotrexate 10mg weekly",
        "Folic Acid 5mg weekly",
        "Ibuprofen 200mg Occasional previously"
      ],
      "impression": "Newly diagnosed seropositive rheumatoid arthritis with active joint inflammation. Initiation of Methotrexate and folic acid supplementation appropriate based on disease activity.",
      "differential_diagnosis": [
        "Seropositive rheumatoid arthritis",
        "Early inflammatory arthritis",
        "Other autoimmune arthropathies (less likely)"
      ],
      "notes": "Acute MTX toxicity episode; MTX and Folic Acid must be stopped; TMP-SMX likely exacerbated toxicity; requires hospital-level care."

    },
    {
      "encounter_no": 2,
      "date": "2016-02-20",
      "type": "General Practice",
      "provider": "GP",
      "medications": [
        "Methotrexate 10mg weekly",
        "Folic Acid 5mg weekly"
      ],
      "impression": "Stable rheumatoid arthritis on current Methotrexate dose with no reported adverse effects. Disease activity remains well controlled.",
      "differential_diagnosis": [
        "Stable rheumatoid arthritis",
        "Quiescent inflammatory arthritis"
      ],
      "notes": "RA stable; MTX tolerated well; no adverse effects noted."

    },
    {
      "encounter_no": 3,
      "date": "2018-09-05",
      "type": "General Practice",
      "provider": "GP",
      "medications": [
        "Methotrexate 20mg weekly",
        "Folic Acid 5mg weekly",
        "Lisinopril 10mg daily"
      ],
      "impression": "New diagnosis of essential hypertension requiring initiation of antihypertensive therapy. Rheumatoid arthritis remains controlled; Methotrexate dose increased to optimise long-term disease suppression.",
      "differential_diagnosis": [
        "Essential hypertension",
        "Rheumatoid arthritis (stable but requiring dose optimisation)",
        "Medication-related BP elevation (less likely)"
      ],
     "notes": "BP persistently elevated; MTX dose escalated; Lisinopril initiated; first signal of cardiovascular/metabolic comorbidity."

    },
    {
      "encounter_no": 4,
      "date": "2021-03-15",
      "type": "General Practice",
      "provider": "GP",
      "medications": [
        "Methotrexate 20mg weekly",
        "Folic Acid 5mg weekly",
        "Lisinopril 10mg daily"
      ],
      "impression": "Rheumatoid arthritis remains well controlled on current Methotrexate regimen. Hypertension well managed on Lisinopril. Mild chronic kidney disease stable with no progression.",
      "differential_diagnosis": [
        "Stable rheumatoid arthritis",
        "Controlled hypertension",
        "Chronic kidney disease (stable stage)"
      ],
    "notes": "CKD noted for the first time; renal function stable; RA continues well controlled."

    },
    {
      "encounter_no": 5,
      "date": "2025-06-15",
      "type": "General Practice",
      "provider": "GP",
      "medications": [
        "Trimethoprim-Sulfamethoxazole 800/160mg BID"
      ],
      "impression": "Acute bacterial sinusitis presenting with congestion, facial pain, and purulent discharge. Underlying rheumatoid arthritis, hypertension, and CKD remain stable.",
      "differential_diagnosis": [
        "Acute bacterial sinusitis",
        "Viral upper respiratory infection",
        "Allergic rhinosinusitis"
      ],
    "notes": "TMP-SMX prescribed—clinically important because it interacts with MTX, increasing DILI and marrow toxicity risk."

    },
    {
      "encounter_no": 6,
      "date": "2025-06-21",
      "type": "Emergency Medicine",
      "provider": "Dr. Sarah Chen",
      "medications": [],
      "impression": "Acute liver injury with jaundice, fatigue, pain, and confusion concerning for drug-induced liver injury and possible severe methotrexate toxicity. Requires urgent evaluation and stabilisation.",
      "differential_diagnosis": [
        "Drug-induced liver injury (likely MTX-related)",
        "Severe methotrexate toxicity",
        "Acute viral hepatitis",
        "Obstructive jaundice"
      ],
     "notes": "Acute MTX toxicity episode; MTX and Folic Acid must be stopped; TMP-SMX likely exacerbated toxicity; requires hospital-level care."

    }
  ],
            "medicationTimeline": [
                {
                    "name": "Methotrexate",
                    "startDate": "2015-08-10",
                    "endDate": "2018-09-05",
                    "dose": "10mg weekly",
                    "indication": "RA"
                },
                {
                    "name": "Methotrexate",
                    "startDate": "2018-09-05",
                                        "endDate": "2025-06-25",

                    "dose": "20mg weekly",
                    "indication": "RA"
                },
                {
                    "name": "Folic Acid",
                    "startDate": "2015-08-10",
                                        "endDate": "2025-06-25",

                    "dose": "5mg weekly",
                    "indication": "MTX supplementation"
                },
                {
                    "name": "Lisinopril",
                    "startDate": "2018-09-05",
                                        "endDate": "2025-06-25",

                    "dose": "10mg daily",
                    "indication": "Hypertension"
                },
                {
                    "name": "Trimethoprim-Sulfamethoxazole",
                    "startDate": "2025-06-15",
                    "endDate": "2025-06-25",
                    "dose": "800/160mg BID",
                    "indication": "Acute bacterial sinusitis"
                }
            ],
            "labTimeline": [
                    {
                    "biomarker": "WBC",
                    "unit": "x10^9/L",
                    "referenceRange": { "min": 4.5, "max": 11.0 },
                    "values": [
                        { "t": "2015-08-10T11:00:00", "value": 7.5 },
                        { "t": "2016-02-20T09:30:00", "value": 6.8 },
                        { "t": "2018-09-05T10:00:00", "value": 7.2 },
                        { "t": "2025-06-15T10:30:00", "value": 6.5 },
                        { "t": "2025-06-21T14:00:00", "value": 5.0 }
                    ]
                    },
                    {
                    "biomarker": "Hemoglobin",
                    "unit": "g/dL",
                    "referenceRange": { "min": 12.0, "max": 16.0 },
                    "values": [
                        { "t": "2015-08-10T11:00:00", "value": 14.5 },
                        { "t": "2018-09-05T10:00:00", "value": 14.0 }
                    ]
                    },
                    {
                    "biomarker": "Platelets",
                    "unit": "x10^9/L",
                    "referenceRange": { "min": 150, "max": 450 },
                    "values": [
                        { "t": "2015-08-10T11:00:00", "value": 270 },
                        { "t": "2018-09-05T10:00:00", "value": 250 }
                    ]
                    },
                    {
                    "biomarker": "ALT",
                    "unit": "U/L",
                    "referenceRange": { "min": 7, "max": 55 },
                    "values": [
                        { "t": "2015-09-05T10:00:00", "value": 35 },
                        { "t": "2025-06-15T10:30:00", "value": 1520 },
                        { "t": "2025-06-21T14:00:00", "value": 1380 }
                    ]
                    },
                    {
                    "biomarker": "AST",
                    "unit": "U/L",
                    "referenceRange": { "min": 8, "max": 48 },
                    "values": [
                        { "t": "2018-09-05T10:00:00", "value": 32 },
                        { "t": "2025-06-15T10:30:00", "value": 1380 },
                        { "t": "2025-06-21T14:00:00", "value": 1200 }
                    ]
                    },
                    {
                    "biomarker": "Alkaline Phosphatase",
                    "unit": "U/L",
                    "referenceRange": { "min": 40, "max": 130 },
                    "values": [
                        { "t": "2018-09-05T10:00:00", "value": 110 },
                        { "t": "2025-06-15T10:30:00", "value": 130 }
                    ]
                    },
                    {
                    "biomarker": "Total Bilirubin",
                    "unit": "mg/dL",
                    "referenceRange": { "min": 0.1, "max": 1.2 },
                    "values": [
                        { "t": "2018-09-05T10:00:00", "value": 0.9 },
                        { "t": "2025-06-15T10:30:00", "value": 8.4 }
                    ]
                    }
                ],
            "keyEvents": [
                {
                "event": "Jaundice onset",
                "t": "2025-06-15T10:30:00",
                "note": "Clinical jaundice first documented; bilirubin significantly elevated."
                },
                {
                "event": "Coagulopathy detected",
                "t": "2025-06-15T10:30:00",
                "note": "INR > 1.5 indicating impaired hepatic synthetic function."
                },
                {
                "event": "Acute hepatic encephalopathy",
                "t": "2025-06-21T14:00:00",
                "note": "Confusion and asterixis observed; GCS 13, disoriented to time/place."
                },
                {
                "event": "N-acetylcysteine infusion started",
                "t": "2025-06-21T14:00:00",
                "note": "Initiated IV NAC protocol due to acute liver injury and encephalopathy."
                },
                {
                "event": "Hepatology consulted",
                "t": "2025-06-21T14:00:00",
                "note": "Urgent hepatology evaluation requested for suspected severe DILI."
                }
            ],
            "riskTimeline": [
                {
                  "t": "2015-08-10T11:00:00",
                  "riskScore": 0.5,
                  "factors": ["Baseline RA", "Normal ALT/AST", "MTX 10mg started"]
                },
                {
                  "t": "2016-02-20T09:30:00",
                  "riskScore": 0.3,
                  "factors": ["Stable RA", "Normal labs"]
                },
                {
                  "t": "2018-09-05T10:00:00",
                  "riskScore": 0.6,
                  "factors": ["MTX dose increased to 20mg", "Still normal labs", "Hypertension diagnosed"]
                },
                {
                  "t": "2025-06-15T10:30:00",
                  "riskScore": 8.5,
                  "factors": [
                    "ALT 1520 U/L",
                    "AST 1380 U/L",
                    "Bilirubin 8.4 mg/dL",
                    "Jaundice onset",
                    "INR > 1.5 (Coagulopathy)",
                    "TMP-SMX added to chronic MTX therapy"
                  ]
                },
                {
                  "t": "2025-06-21T14:00:00",
                  "riskScore": 9.6,
                  "factors": [
                    "Severe DILI",
                    "ALT 1380 U/L (persistent)",
                    "AST 1200 U/L (persistent)",
                    "Acute hepatic encephalopathy",
                    "NAC infusion started",
                    "Specialist hepatology consult"
                  ]
                }
            ],
            "causalChain": [
                { "title": "MTX Exposure", "description": "RA treatment, chronic use" },
                { "title": "Underlying Risk Factors", "description": "MASH/MASLD, BMI 30, steatosis, long-term MTX" },
                { "title": "Early Warning Signs Missed", "description": "May–July: rising ALT → 150 → 260 U/L, nausea, fatigue" },
                { "title": "Continued MTX Despite Hepatotoxicity", "description": "Critical prescribing oversight → delayed cessation" },
                { "title": "Toxic Accumulation of MTX", "description": "In diseased liver; steatotic hepatocytes + impaired clearance" },
                { "title": "Acute Hepatocellular Injury", "description": "Aug 11 labs: ALT 490, AST 350" },
                { "title": "Cholestatic Features Develop", "description": "Bilirubin 110 → 190 µmol/L, dark urine, jaundice" },
                { "title": "Crisis Presentation", "description": "Severe nausea, anorexia, jaundice → ED referral" },
                { "title": "Diagnosis", "description": "Severe MTX-induced DILI (RUCAM 9/10, hepatocellular → cholestatic pattern)" },
                { "title": "Immediate MTX Cessation + NAC", "description": "Rapid stabilization; INR preserved throughout" },
                { "title": "Clinical Course", "description": "ALT falling (490 → 420); Bilirubin peaks but expected slow decline; No encephalopathy" },
                { "title": "Outcome", "description": "Severe DILI confirmed; MTX permanently contraindicated; Long-term follow-up for MASH & fibrosis" }
            ]
        }
    },
    "createdAt": "2025-10-14T16:47:56.098Z",
    "updatedAt": "2025-10-14T16:47:56.098Z"
}